PROLASTIN-C

This brand name is authorized in Brazil, Canada, Turkey, United States

Active ingredients

The drug PROLASTIN-C contains one active pharmaceutical ingredient (API):

1 Alfa1 antitrypsin UNII F43I396OIS - .ALPHA.1-PROTEINASE INHIBITOR HUMAN

Human alpha1-proteinase inhibitor is understood to be the primary anti-protease in the lower respiratory tract, where it inhibits neutrophil elastase (NE). Normal healthy individuals produce sufficient alpha1-proteinase inhibitor to control the NE produced by activated neutrophils and are thus able to prevent inappropriate proteolysis of lung tissue by NE. Read about Alfa1 antitrypsin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROLASTIN-C Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02AB02	Alfa1 antitrypsin	B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AB Proteinase inhibitors
Discover more medicines within B02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510918100005307
Country: CA	Health Products and Food Branch	Identifier(s): 02204606
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699769980351
Country: US	FDA, National Drug Code	Identifier(s): 13533-000, 13533-100, 13533-200, 13533-700, 13533-705